Rocket Pharmaceuticals (NASDAQ:RCKT) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Rocket Pharmaceuticals missed estimated earnings by 22.06%, reporting an EPS of $-0.83 versus an estimate of $-0.68.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 5.5% drop in the share price the next day.
To track all earnings releases for Rocket Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
